Raykov Rosty bought FENC
April 30, 2026 · Form 4 insider transaction
Raykov Rosty bought 2,778 shares of Fennec Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
2,778
Price
$0.00
Total value
N/A
InsiderRaykov Rosty
RoleDirector
SecurityCommon shares
Transaction codeM: Option exercise
Transaction dateApril 30, 2026
Filing dateMay 1, 2026
Shares owned after116,634
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares released from restriction from shares awarded 5/16/2024.